Hetacillin

DB00739

small molecule approved vet_approved withdrawn

Deskripsi

Hetacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Hetacillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Hetacillin results from the inhibition of cell wall synthesis and is mediated through Hetacillin binding to penicillin binding proteins (PBPs). Hetacillin has been withdrawn from the market since it has been discovered that it has no therapeutic advantage compared to non-ester derivatives like ampicillin.

Struktur Molekul 2D

Berat 389.469
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Hydrolyzed to active ampicillin via esterases

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

192 Data
Methotrexate The excretion of Methotrexate can be decreased when combined with Hetacillin.
Probenecid The excretion of Hetacillin can be decreased when combined with Probenecid.
Doxycycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Doxycycline.
Lymecycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Lymecycline.
Clomocycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Clomocycline.
Tigecycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Tigecycline.
Oxytetracycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Oxytetracycline.
Demeclocycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Demeclocycline.
Tetracycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Tetracycline.
Metacycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Metacycline.
Minocycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Minocycline.
Rolitetracycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Rolitetracycline.
Sarecycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Sarecycline.
Eravacycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Eravacycline.
Omadacycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Omadacycline.
Penimepicycline The therapeutic efficacy of Hetacillin can be decreased when used in combination with Penimepicycline.
Mycophenolate mofetil The serum concentration of Mycophenolate mofetil can be decreased when it is combined with Hetacillin.
Mycophenolic acid The serum concentration of Mycophenolic acid can be decreased when it is combined with Hetacillin.
Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Hetacillin.
Diethylstilbestrol The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Hetacillin.
Etonogestrel The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Hetacillin.
Desogestrel The therapeutic efficacy of Desogestrel can be decreased when used in combination with Hetacillin.
Megestrol acetate The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Hetacillin.
Levonorgestrel The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Hetacillin.
Progesterone The therapeutic efficacy of Progesterone can be decreased when used in combination with Hetacillin.
Medroxyprogesterone acetate The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Hetacillin.
Norethisterone The therapeutic efficacy of Norethisterone can be decreased when used in combination with Hetacillin.
Estradiol The therapeutic efficacy of Estradiol can be decreased when used in combination with Hetacillin.
Ethynodiol diacetate The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Hetacillin.
Mifepristone The therapeutic efficacy of Mifepristone can be decreased when used in combination with Hetacillin.
Norgestimate The therapeutic efficacy of Norgestimate can be decreased when used in combination with Hetacillin.
Ethinylestradiol The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Hetacillin.
Mestranol The therapeutic efficacy of Mestranol can be decreased when used in combination with Hetacillin.
Drospirenone The therapeutic efficacy of Drospirenone can be decreased when used in combination with Hetacillin.
Estrone sulfate The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Hetacillin.
Octylphenoxy polyethoxyethanol The therapeutic efficacy of Octylphenoxy polyethoxyethanol can be decreased when used in combination with Hetacillin.
Cyproterone acetate The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Hetacillin.
Trestolone The therapeutic efficacy of Trestolone can be decreased when used in combination with Hetacillin.
Norelgestromin The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Hetacillin.
Gestodene The therapeutic efficacy of Gestodene can be decreased when used in combination with Hetacillin.
Hydroxyprogesterone caproate The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Hetacillin.
Ulipristal The therapeutic efficacy of Ulipristal can be decreased when used in combination with Hetacillin.
Dienogest The therapeutic efficacy of Dienogest can be decreased when used in combination with Hetacillin.
Norethynodrel The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Hetacillin.
Norgestrel The therapeutic efficacy of Norgestrel can be decreased when used in combination with Hetacillin.
Cloprostenol The therapeutic efficacy of Cloprostenol can be decreased when used in combination with Hetacillin.
Gestrinone The therapeutic efficacy of Gestrinone can be decreased when used in combination with Hetacillin.
Nomegestrol The therapeutic efficacy of Nomegestrol can be decreased when used in combination with Hetacillin.
Lynestrenol The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Hetacillin.
Gossypol The therapeutic efficacy of Gossypol can be decreased when used in combination with Hetacillin.
Ormeloxifene The therapeutic efficacy of Ormeloxifene can be decreased when used in combination with Hetacillin.
Chlormadinone The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Hetacillin.
Norgestrienone The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Hetacillin.
Quingestanol The therapeutic efficacy of Quingestanol can be decreased when used in combination with Hetacillin.
Demegestone The therapeutic efficacy of Demegestone can be decreased when used in combination with Hetacillin.
Etynodiol The therapeutic efficacy of Etynodiol can be decreased when used in combination with Hetacillin.
Testosterone enanthate The therapeutic efficacy of Testosterone enanthate can be decreased when used in combination with Hetacillin.
Estradiol benzoate The therapeutic efficacy of Estradiol benzoate can be decreased when used in combination with Hetacillin.
Estradiol cypionate The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Hetacillin.
Estradiol valerate The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Hetacillin.
Nomegestrol acetate The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Hetacillin.
Norethindrone enanthate The therapeutic efficacy of Norethindrone enanthate can be decreased when used in combination with Hetacillin.
Capreomycin The serum concentration of Capreomycin can be decreased when it is combined with Hetacillin.
Framycetin The serum concentration of Framycetin can be decreased when it is combined with Hetacillin.
Amikacin The serum concentration of Amikacin can be decreased when it is combined with Hetacillin.
Tobramycin The serum concentration of Tobramycin can be decreased when it is combined with Hetacillin.
Gentamicin The serum concentration of Gentamicin can be decreased when it is combined with Hetacillin.
Netilmicin The serum concentration of Netilmicin can be decreased when it is combined with Hetacillin.
Neomycin The serum concentration of Neomycin can be decreased when it is combined with Hetacillin.
Streptomycin The serum concentration of Streptomycin can be decreased when it is combined with Hetacillin.
Kanamycin The serum concentration of Kanamycin can be decreased when it is combined with Hetacillin.
Paromomycin The serum concentration of Paromomycin can be decreased when it is combined with Hetacillin.
Ribostamycin The serum concentration of Ribostamycin can be decreased when it is combined with Hetacillin.
Geneticin The serum concentration of Geneticin can be decreased when it is combined with Hetacillin.
Apramycin The serum concentration of Apramycin can be decreased when it is combined with Hetacillin.
Gentamicin C1a The serum concentration of Gentamicin C1a can be decreased when it is combined with Hetacillin.
Neamine The serum concentration of Neamine can be decreased when it is combined with Hetacillin.
Arbekacin The serum concentration of Arbekacin can be decreased when it is combined with Hetacillin.
Puromycin The serum concentration of Puromycin can be decreased when it is combined with Hetacillin.
Dihydrostreptomycin The serum concentration of Dihydrostreptomycin can be decreased when it is combined with Hetacillin.
Hygromycin B The serum concentration of Hygromycin B can be decreased when it is combined with Hetacillin.
Sisomicin The serum concentration of Sisomicin can be decreased when it is combined with Hetacillin.
Plazomicin The serum concentration of Plazomicin can be decreased when it is combined with Hetacillin.
Isepamicin The serum concentration of Isepamicin can be decreased when it is combined with Hetacillin.
Colistin The serum concentration of Colistin can be decreased when it is combined with Hetacillin.
BCG vaccine The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Hetacillin.
Typhoid vaccine The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Hetacillin.
Acemetacin Acemetacin may decrease the excretion rate of Hetacillin which could result in a higher serum level.
Dicoumarol Hetacillin may increase the anticoagulant activities of Dicoumarol.
Phenindione Hetacillin may increase the anticoagulant activities of Phenindione.
Warfarin Hetacillin may increase the anticoagulant activities of Warfarin.
Phenprocoumon Hetacillin may increase the anticoagulant activities of Phenprocoumon.
Acenocoumarol Hetacillin may increase the anticoagulant activities of Acenocoumarol.
4-hydroxycoumarin Hetacillin may increase the anticoagulant activities of 4-hydroxycoumarin.
Coumarin Hetacillin may increase the anticoagulant activities of Coumarin.
(R)-warfarin Hetacillin may increase the anticoagulant activities of (R)-warfarin.
Ethyl biscoumacetate Hetacillin may increase the anticoagulant activities of Ethyl biscoumacetate.
Fluindione Hetacillin may increase the anticoagulant activities of Fluindione.
Clorindione Hetacillin may increase the anticoagulant activities of Clorindione.
Diphenadione Hetacillin may increase the anticoagulant activities of Diphenadione.

Target Protein

Penicillin-binding protein 2a pbp2a
Penicillin-binding protein 1b pbp1b
Penicillin-binding protein 3 pbp3
Penicillin-binding protein 1A pbpA
Penicillin-binding protein 2B penA

Referensi & Sumber

Synthesis reference: U.S. Patent 3,198,804.
Artikel (PubMed)
  • PMID: 4597707
    Faine S, Harper M: Independent antibiotic actions of hetacillin and ampicillin revealed by fast methods. Antimicrob Agents Chemother. 1973 Jan;3(1):15-8. doi: 10.1128/aac.3.1.15.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Natacillin — Bristol-Myers Squibb
  • Versapen — Bristol-Myers Squibb

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul